physostigmine has been researched along with Dyskinesia, Medication-Induced in 37 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 33 (89.19) | 18.7374 |
1990's | 3 (8.11) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (2.70) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arai, M; Arikawa-Hirasawa, E; Arinami, T; Horiuchi, Y; Inada, T; Iritani, S; Ishiguro, H; Ishikawa, M; Itokawa, M; Kakita, A; Keino-Masu, K; Nawa, H; Niizato, K; Ozaki, N; Syu, A; Takahashi, H; Takahashi, M; Tanaka, S | 1 |
Ciraulo, DA; Shader, RI; Weiss, KJ | 1 |
Bowers, MB; Moore, DC | 1 |
Edge, PC; Grell, GA; Melville, GN; Wray, SR | 1 |
Feinsilver, DL | 1 |
Jeste, DV; Wyatt, RJ | 1 |
Alphs, LD; Davis, JM | 1 |
Gelenberg, AJ | 1 |
Coco, A; Davis, KL; Deutsch, SI; Horvath, T; Levy, MI; Mohs, RC; Rothpearl, AB; Stockton, D | 1 |
Berger, PA; Stahl, SM; Yesavage, JA | 1 |
Dysken, MW; Goetz, CG; Klawans, HL | 1 |
Corkin, S; Growdon, JH | 1 |
Chesler, EJ; Salamone, JD | 1 |
Asper, H; Bürki, HR; Ruch, W; Sayers, AC | 1 |
Carroll, BJ; Curtis, GC; Kokmen, E | 1 |
Christensen, AV; Nielsen, IM | 1 |
Barchas, JD; Berger, PA; Davis, KL; Hollister, LE | 1 |
Berger, PA; Davis, KL; Hollister, LE; Simonton, SC | 1 |
Bralower, M; Tarsy, D | 1 |
Casey, DE | 1 |
Berger, PA; Davis, KL | 1 |
Growdon, JH; Wurtman, RJ | 1 |
Berger, PA; Davis, KL; Hollister, LE; Vento, AL | 1 |
Lakke, JP; Lindeboom, SF | 1 |
Casey, DE; Denney, D | 1 |
Boueilh, P; Bourgeois, M; Gauthier-Bernard, F; Peyre, C | 1 |
Bourgeois, M | 1 |
Carlson, KR; Eibergen, RD | 2 |
Berger, PA; Davis, KL; De Fraites, EG | 1 |
Chang, S; Crayton, JW; Ericksen, SE; Klass, D; Smith, RC | 1 |
Chang, S; Davis, JM; Ericksen, SE; Smith, RC; Tamminga, CA | 1 |
Chee, KY; Sachdev, P | 1 |
Boyce, S; Iversen, SD; Rupniak, NM; Steventon, MJ; Tye, SJ | 1 |
Rektor, J | 1 |
Millar, WL; Swerdlow, NR; Weinger, MB | 1 |
Camarena, ML; Moss, DE; Reyes, E; Rodriguez, LA | 1 |
5 review(s) available for physostigmine and Dyskinesia, Medication-Induced
Article | Year |
---|---|
Current concepts of abnormal motor disorder: an experimental model of attentional deficit disorder.
Topics: Amphetamine; Animals; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Avoidance Learning; Brain; Cholinesterase Inhibitors; Dyskinesia, Drug-Induced; gamma-Aminobutyric Acid; Humans; Huntington Disease; Hyperkinesis; Models, Neurological; Movement Disorders; Nervous System Diseases; Neurotransmitter Agents; Parkinson Disease; Physostigmine; Rats | 1981 |
Therapeutic strategies against tardive dyskinesia. Two decades of experience.
Topics: Antipsychotic Agents; Choline; Clinical Trials as Topic; Deanol; Dopamine Antagonists; Double-Blind Method; Dyskinesia, Drug-Induced; Humans; Parasympatholytics; Phosphatidylcholines; Physostigmine | 1982 |
Cholinergic treatments for tardive dyskinesia.
Topics: Acetylcholine; Antipsychotic Agents; Choline; Clinical Trials as Topic; Corpus Striatum; Deanol; Dopamine; Dyskinesia, Drug-Induced; Humans; Parasympathomimetics; Phosphatidylcholines; Physostigmine; Research Design; Substance Withdrawal Syndrome | 1983 |
Use and abuse of anticholinergic drugs in psychiatry.
Topics: Aged; Basal Ganglia Diseases; Delirium; Dyskinesia, Drug-Induced; Humans; Parasympatholytics; Parkinson Disease, Secondary; Physostigmine; Psychiatry; Psychotropic Drugs; Receptors, Cholinergic; Substance-Related Disorders | 1984 |
Deanol in the management of involuntary movement disorders: a review.
Topics: Acetylcholine; Deanol; Dopamine; Dyskinesia, Drug-Induced; Ethanolamines; Female; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Models, Neurological; Movement Disorders; Parkinson Disease; Physostigmine; Research Design; Time Factors | 1977 |
10 trial(s) available for physostigmine and Dyskinesia, Medication-Induced
Article | Year |
---|---|
Therapeutic strategies against tardive dyskinesia. Two decades of experience.
Topics: Antipsychotic Agents; Choline; Clinical Trials as Topic; Deanol; Dopamine Antagonists; Double-Blind Method; Dyskinesia, Drug-Induced; Humans; Parasympatholytics; Phosphatidylcholines; Physostigmine | 1982 |
Cholinergic treatments for tardive dyskinesia.
Topics: Acetylcholine; Antipsychotic Agents; Choline; Clinical Trials as Topic; Corpus Striatum; Deanol; Dopamine; Dyskinesia, Drug-Induced; Humans; Parasympathomimetics; Phosphatidylcholines; Physostigmine; Research Design; Substance Withdrawal Syndrome | 1983 |
Deanol acetamidobenzoate treatment in choreiform movement disorders.
Topics: Benztropine; Clinical Trials as Topic; Deanol; Double-Blind Method; Drug Evaluation; Dyskinesia, Drug-Induced; Ethanolamines; Humans; Huntington Disease; Male; Middle Aged; Physostigmine | 1977 |
Pharmacological investigations of the cholinergic imbalance hypotheses of movement disorders and psychosis.
Topics: Acetylcholine; Adult; Aged; Bipolar Disorder; Brain; Choline; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Huntington Disease; Male; Middle Aged; Movement Disorders; Physostigmine; Psychotic Disorders; Receptors, Cholinergic; Schizophrenia | 1978 |
Dietary enhancement of CNS neurotransmitters.
Topics: Acetylcholine; Administration, Oral; Brain; Choline; Clinical Trials as Topic; Diet; Dyskinesia, Drug-Induced; Humans; Huntington Disease; Physostigmine; Serotonin; Tryptophan | 1978 |
Studies on choline chloride in neuropsychiatric disease: human and animal data.
Topics: Animals; Choline; Clinical Trials as Topic; Disease Models, Animal; Drug Evaluation; Dyskinesia, Drug-Induced; Humans; Huntington Disease; Physostigmine; Rats | 1978 |
Deanol and physostigmine in the treatment of L-dopa-induced dyskinesias.
Topics: Aged; Clinical Trials as Topic; Deanol; Double-Blind Method; Drug Evaluation; Dyskinesia, Drug-Induced; Ethanolamines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Physostigmine; Placebos | 1978 |
Pharmacological characterization of tardive dyskinesia.
Topics: Adult; Benztropine; Clinical Trials as Topic; Deanol; Dopamine; Droperidol; Dyskinesia, Drug-Induced; Humans; Levodopa; Male; Middle Aged; Parasympatholytics; Physostigmine; Placebos; Time Factors | 1977 |
Cholinergic influences in tardive dyskinesia.
Topics: Acetylcholine; Administration, Oral; Basal Ganglia; Choline; Deanol; Dyskinesia, Drug-Induced; Ethanolamines; Humans; Hypnotics and Sedatives; Injections, Intravenous; Methohexital; Motor Activity; Neostigmine; Physostigmine; Placebos; Receptors, Dopamine | 1977 |
Pharmacological characterization of tardive akathisia.
Topics: Administration, Oral; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Arousal; Atenolol; Benztropine; Brain; Bromocriptine; Chronic Disease; Clonidine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Dyskinesia, Drug-Induced; Humans; Infusions, Intravenous; Male; Metoclopramide; Metoprolol; Physostigmine; Propranolol; Psychomotor Agitation; Schizophrenia, Paranoid | 1990 |
24 other study(ies) available for physostigmine and Dyskinesia, Medication-Induced
Article | Year |
---|---|
Association of the HSPG2 gene with neuroleptic-induced tardive dyskinesia.
Topics: Animals; Antipsychotic Agents; Cholinesterase Inhibitors; Dyskinesia, Drug-Induced; Female; Genetic Association Studies; Haloperidol; Heparan Sulfate Proteoglycans; Humans; Japan; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Physostigmine; Polymorphism, Single Nucleotide; Prefrontal Cortex; Reserpine; Schizophrenia | 2010 |
Physostigmine test in the rabbit syndrome and tardive dyskinesia.
Topics: Aged; Antipsychotic Agents; Diagnosis, Differential; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Physostigmine | 1980 |
Identification of a subgroup of tardive dyskinesia patients by pharmacologic probes.
Topics: Acetylcholine; Antipsychotic Agents; Benztropine; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Humans; Male; Physostigmine; Receptors, Dopamine | 1980 |
Antipsychotic medications: guidelines for use in emergencies.
Topics: Adult; Aged; Antipsychotic Agents; Child; Delirium; Dopamine Antagonists; Dyskinesia, Drug-Induced; Emergencies; Family Practice; Histamine H1 Antagonists; Humans; Hypotension; Parasympatholytics; Physostigmine; Psychotic Disorders; Sympathomimetics | 1982 |
Acetylcholinesterase activity in CSF in schizophrenia, depression, Alzheimer's disease and normals.
Topics: Acetylcholinesterase; Adult; Aged; Alzheimer Disease; Cerebrospinal Fluid Proteins; Cholinesterase Inhibitors; Depressive Disorder; Dyskinesia, Drug-Induced; Humans; Middle Aged; Physostigmine; Schizophrenia | 1983 |
Pharmacologic characteristics of Meige dystonia: differentiation from tardive dyskinesia.
Topics: Acetylcholine; Blepharospasm; Diagnosis, Differential; Dopamine; Dyskinesia, Drug-Induced; Dystonia; Facial Muscles; Humans; Male; Middle Aged; Physostigmine | 1982 |
Assessment and treatment of drug-induced tremor.
Topics: Aged; Benztropine; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Paranoid Disorders; Physostigmine | 1980 |
Neurochemical approaches to the treatment of senile dementia.
Topics: Acetylcholine; Aged; Alzheimer Disease; Animals; Choline; Choline O-Acetyltransferase; Dementia; Dyskinesia, Drug-Induced; Female; Humans; Learning; Male; Memory; Middle Aged; Phosphatidylcholines; Physostigmine; Rats; Receptors, Cholinergic | 1980 |
Effects of acute and repeated clozapine injections on cholinomimetic-induced vacuous jaw movements.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Clozapine; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Hypnotics and Sedatives; Male; Parasympathomimetics; Physostigmine; Pilocarpine; Rats; Rats, Sprague-Dawley | 1996 |
Anticholinergic properties of antipsychotic drugs and their relation to extrapyramidal side-effects.
Topics: Animals; Antipsychotic Agents; Atropine; Basal Ganglia Diseases; Clozapine; Corpus Striatum; Drug Interactions; Dyskinesia, Drug-Induced; Female; Haloperidol; Homovanillic Acid; Male; Parasympathetic Nervous System; Physostigmine; Rats; Receptors, Dopamine; Receptors, Muscarinic | 1976 |
Paradoxical response to dopamine agonists in tardive dyskinesia.
Topics: Adrenergic alpha-Agonists; Adult; Amantadine; Apomorphine; Benztropine; Clozapine; Deanol; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Antagonism; Drug Tolerance; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Levodopa; Physostigmine; Receptors, Dopamine; Reserpine; Stimulation, Chemical; Thioridazine | 1977 |
Dopaminergic supersensitivity: influence of dopamine agonists, cholinergics, anticholinergics, and drugs used for the treatment of tardive dyskinesia.
Topics: Animals; Antiparkinson Agents; Apomorphine; Atropine; Dopamine; Drug Synergism; Dyskinesia, Drug-Induced; Flupenthixol; Humans; Male; Methylphenidate; Mice; Muscimol; Parasympatholytics; Parasympathomimetics; Phenobarbital; Physostigmine; Stereotyped Behavior | 1979 |
Choline in tardive dyskinesia and Huntington's disease.
Topics: Choline; Dyskinesia, Drug-Induced; Humans; Huntington Disease; Male; Physostigmine | 1976 |
Choline chloride in the treatment of Huntington's disease and tardive dyskinesia: a preliminary report.
Topics: Choline; Dyskinesia, Drug-Induced; Humans; Huntington Disease; Physostigmine | 1977 |
[Neuroleptic tardive dyskinesias. Completion of the inquiry regarding 1,480 psychiatric hospital patients].
Topics: Age Factors; Aged; Child; Choline; Dyskinesia, Drug-Induced; Female; Hospitals, Psychiatric; Humans; Male; Middle Aged; Physostigmine; Schizophrenia; Tranquilizing Agents | 1977 |
[Tardive Dyskinesia induced by neuroleptics: a survey of 3140 patients in a psychiatric hospital].
Topics: Aged; Antiparkinson Agents; Basal Ganglia Diseases; Chlorpromazine; Diagnosis, Differential; Dyskinesia, Drug-Induced; Female; France; Humans; Iatrogenic Disease; Male; Mental Disorders; Middle Aged; Physostigmine; Reserpine; Retrospective Studies; Tranquilizing Agents; Tyrosine | 1977 |
Dyskinesias in monkeys: interaction of methamphetamine with prior methadone treatment.
Topics: Animals; Chlorpromazine; Clozapine; Diazepam; Dyskinesia, Drug-Induced; Haloperidol; Haplorhini; Humans; Macaca mulatta; Male; Methadone; Methamphetamine; Naloxone; Phenobarbital; Phentolamine; Physostigmine; Spiperone; Stereotyped Behavior | 1976 |
Susceptibility to amphetamine-elicited dyskinesias following chronic methadone treatment in monkeys.
Topics: Animals; Chlorpromazine; Clozapine; Diazepam; Drug Interactions; Dyskinesia, Drug-Induced; Haloperidol; Haplorhini; Macaca mulatta; Male; Methadone; Methamphetamine; Phenobarbital; Phentolamine; Physostigmine; Spiperone; Time Factors | 1976 |
Coexisting tardive dyskinesia and parkinsonism: a case report.
Topics: Acetylcholine; Adult; Benztropine; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; Fluphenazine; Haloperidol; Humans; Male; Parkinson Disease, Secondary; Physostigmine; Schizophrenia, Paranoid; Thioridazine; Tranquilizing Agents | 1977 |
Electrophysiological (H-reflex) studies of patients with tardive dyskinesia.
Topics: Amphetamine; Apomorphine; Deanol; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Electrophysiology; H-Reflex; Humans; Motor Neurons; Muscles; Neurons, Afferent; Physostigmine; Receptors, Dopamine; Reflex, Monosynaptic; Schizophrenia | 1977 |
Spontaneous orofacial dyskinesias in a captive cynomolgus monkey: implications for tardive dyskinesia.
Topics: Animals; Benzazepines; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Facial Expression; Facial Muscles; Haloperidol; Macaca fascicularis; Mastication; Movement Disorders; Physostigmine; Scopolamine; Stereotyped Behavior | 1990 |
[The cholinergic system in the pathophysiology of tardive dyskinesia].
Topics: Adult; Aged; Atropine; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Parasympathetic Nervous System; Physostigmine | 1988 |
Acute postoperative delirium and extrapyramidal signs in a previously healthy parturient.
Topics: Adult; Anesthesia, Epidural; Anesthesia, Obstetrical; Cesarean Section; Delirium; Dyskinesia, Drug-Induced; Female; Fentanyl; Humans; Lidocaine; Physostigmine; Postoperative Complications; Pregnancy; Puerperal Disorders | 1988 |
Perioral behaviors induced by cholinesterase inhibitors: a controversial animal model.
Topics: Animals; Behavior, Animal; Cholinesterase Inhibitors; Disease Models, Animal; Dopamine Antagonists; Dyskinesia, Drug-Induced; Female; Phenylmethylsulfonyl Fluoride; Physostigmine; Rats; Rats, Inbred Strains; Stereotyped Behavior; Sulfones | 1986 |